Expression of podoplanin, CD44, and p63 in squamous cell carcinoma of the lung
Open Access
- 11 October 2009
- journal article
- Published by Wiley in Cancer Science
- Vol. 100 (11), 2054-2059
- https://doi.org/10.1111/j.1349-7006.2009.01295.x
Abstract
Recent molecular biological studies have identified podoplanin as a candidate cancer stem cell (CSC) marker in squamous cell carcinoma (SqCC). The purpose of this study was to examine the expression pattern of podoplanin, and the other stem cell markers CD44 and p63, and their relationship to clinico-pathological features including survival in pulmonary SqCC. We examined histologically the expression of podoplanin, CD44, and p63 in 162 consecutive SqCC by immunostaining. Podoplanin expression was observed in 107 (66%) tumors, CD44 in 145 (89.5%), and p63 in 151 (93.2%), respectively. In 95.3% of the podoplanin-positive tumors, tumor cells showing strong expression were localized in the periphery of the tumor nests. However, this peripheral localization was observed in only 55.9% of the CD44-positive and 43% of p63-positive tumors. In 88.8% of the podoplanin-positive tumors, positive cells were localized more peripherally in the tumor nests than CD44- or p63-positive cells and when CD44 and p63 expressions were compared in these podoplanin-positive tumors, p63-positive layers in the periphery of the tumor nests were broader compared to CD44-positive layers. These findings suggest tumor cells are aligned in the “hierarchical distribution pattern” according to the expression of these three markers. Patients who had podoplanin-positive tumors with the “hierarchical pattern” resulted in significantly better overall survival than those who had podoplanin-negative tumors (P = 0.043). These results suggest that podoplanin expression would reflect the most immature status in the differentiation process of SqCC, and SqCC with hierarchical expression would be a well-organized tumor group with lower biological aggressiveness based on the CSC concept. (Cancer Sci 2009)Keywords
This publication has 22 references indexed in Scilit:
- Efficient tumour formation by single human melanoma cellsNature, 2008
- Podoplanin Is a Novel Fos Target Gene in Skin CarcinogenesisCancer Research, 2008
- Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431Biochemical and Biophysical Research Communications, 2008
- Cancer Stem Cells and the Ontogeny of Lung CancerJournal of Clinical Oncology, 2008
- ΔNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neckThe Journal of Pathology, 2007
- Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinomaProceedings of the National Academy of Sciences of the United States of America, 2007
- Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transitionJournal of Cell Science, 2006
- Overexpression of podoplanin in oral cancer and its association with poor clinical outcomeCancer, 2006
- Erlotinib in Previously Treated Non–Small-Cell Lung CancerThe New England Journal of Medicine, 2005
- Characterization of human PA2.26 antigen (T1α-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomasInternational Journal of Cancer, 2004